American College of Cardiology

JUNE 24, 2024

Semaglutide reduces body weight to a greater extent in women with obesity-related heart failure with preserved ejection fraction (HFpEF) than in men, and improved Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS) to the same extent in both women and men, according to results from a prespecified secondary analysis of pooled (..)

Preserved Ejection Fraction 65

Preserved Ejection Fraction Obesity Heart Failure Cardiomyopathy 65

Journal of the American Heart Association

DECEMBER 29, 2023

AF increases the risk of stroke, heart failure, dementia, and hospitalization. Obesity significantly increases AF risk, both directly and indirectly, through related conditions, like hypertension, diabetes, and heart failure. ABSTRACTAtrial fibrillation (AF) is the most common cardiac arrhythmia.

Obesity 45

Obesity Atrial Fibrillation Heart Failure Dementia 45

Frontiers in Cardiovascular Medicine

DECEMBER 17, 2023

These conditions have an increasing share in the health burden worldwide due to worsening endemic of hypertension, obesity, and diabetes. However, the same set of genes were significantly induced in the Trp53inp2-cKO hearts under both mechanical and metabolic stresses.

Heart Failure 64

Heart Failure Diet Obesity Diabetes 64

Open Heart

MAY 23, 2024

Pre-eclampsia and heart failure have common risk factors, including hypertension, obesity and diabetes. It is not known whether heart failure increases the risk of pre-eclampsia. This study examines whether pregestational heart failure increases the risk of pre-eclampsia.

Heart Disease 98

Heart Disease Heart Failure Risk Factors Obesity 98

Cardiometabolic Health Congress

JULY 25, 2023

Can you please explain the concept of an obesity paradox? Salvatore Carbone, PhD: First, I’d like to point out that obesity is a major risk factor for cardiometabolic disease. 2, 3] This association is more pronounced for those with class I obesity, which is a body mass index (BMI) between 30-35 kg/m2.

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

CardiacWire

AUGUST 23, 2024

It looks like we might be able to add prediabetes and hypertension to the growing list of conditions that Eli Lilly’s “weight loss drug” tirzepatide is able to treat, after new analysis of the SURMOUNT-1 trial showed significant reductions in blood pressure and diabetes progression. mm Hg systolic and 4.2 of placebo-takers.

Hypertension 64

Hypertension Blood Pressure Diabetes Obesity 64

Science Daily - Heart Disease

JUNE 23, 2024

Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves symptoms in men and women with a common type of heart failure that has had few therapeutic options. Women experienced greater weight loss and the same symptom benefits compared with men.

Obesity 71

Obesity Heart Failure Diabetes 71

HeartRhythm

MARCH 12, 2024

Diabetes mellitus (DM) is a public health problem that continues to grow worldwide. 2 As noted elsewhere,3 DM and AF affect a population that shares concomitant conditions such as obesity, hypertension and even heart failure (HF). of the population.1 of the population.1 Further, DM is a major risk for AF.

Atrial Fibrillation 40

Atrial Fibrillation Diabetes Public Health Obesity 40

Circulation: Heart Failure

MARCH 8, 2024

Circulation: Heart Failure, Ahead of Print. Background:Current prevalence estimates of heart failure (HF) are primarily based on self-report or HF hospitalizations. Results:Median age was 73 (25th–75th percentile 67–81) years, 53.2% were female, 25.6% were Black, 12.8% were Chinese, and 40.0% were White.

Heart Failure 40

Heart Failure Atherosclerosis Kidney Disease Risk Factors 40

American College of Cardiology

AUGUST 30, 2024

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing serious COVID-19-related events and improving heart failure (HF) symptoms, according to six new substudies published in JACC.

COVID-19 40

COVID-19 Obesity Heart Failure Outcomes 40

All About Cardiovascular System and Disorders

FEBRUARY 27, 2024

They have a greater prevalence of obesity, dyslipidemia, metabolic syndrome and diabetes mellitus. Higher risk of myocardial infarction, heart failure and atrial fibrillation was noted in spinal cord injury survivors compared to controls. Survivors with severe disability had the highest risk. Am J Phys Med Rehabil.

Myocardial Infarction 40

Myocardial Infarction Atrial Fibrillation Heart Failure Blood Pressure 40

Nature Reviews - Cardiology

MAY 27, 2024

Nature Reviews Cardiology, Published online: 28 May 2024; doi:10.1038/s41569-024-01042-w In patients with type 2 diabetes mellitus and obesity, bariatric metabolic surgery is associated with a lower risk of the incidence of first-ever congestive heart failure than treatment with glucagon-like peptide 1 receptor agonists, according to a new study.

Obesity 42

Obesity Heart Failure Diabetes 42

American College of Cardiology

FEBRUARY 12, 2024

What is the value of the new American Heart Association’s (AHA’s) PREVENT equation(s) for primary prevention that use routinely available clinical variables including obesity, diabetes, kidney disease, and social risk for predicting 10- and 30-year absolute risk of cardiovascular disease (CVD) including each atherosclerotic CVD (ASCVD) and heart (..)

Kidney Disease 54

Kidney Disease Obesity Heart Failure Cardiovascular Disease 54

Journal of Cardiovascular Pharmacology

JUNE 24, 2024

Sodium/glucose cotransporter 2 (SGLT2) inhibitors are a novel class of anti-diabetic medications which have proved capable of providing breakthrough cardiovascular benefits in a variety of clinical scenarios, including patients with heart failure or obesity, irrespective of diabetic status.

Myocardial Infarction 40

Myocardial Infarction Heart Failure Pharmacology Diabetes 40

Dr. Paddy Barrett

AUGUST 9, 2024

The 14 Factors Include: Hearing Loss High LDL cholesterol Less Education Traumatic Brain Injury Depression Social Isolation Hypertension Obesity Smoking Excess Alcohol Diabetes Physical Inactivity Air Pollution Visual Loss Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission When You Intervene Matters.

Dementia 96

Dementia Blood Pressure Obesity Cholesterol 96

Frontiers in Cardiovascular Medicine

FEBRUARY 4, 2024

Notably, MAM exhibits various regulatory effects to maintain cellular balance in several cardiac diseases conditions, such as obesity, diabetes mellitus, and cardiotoxicity. Cardiac diseases caused by any reason can lead to changes in myocardial structure and function, significantly impacting human health.

Pharmacology 69

Pharmacology Obesity Heart Failure Diabetes 69

Circulation

JUNE 4, 2024

Diabetes (16.3% to 26.8%) and obesity (43.1% to 9.2%), heart failure (2.7% We projected through 2050, overall and by age and race and ethnicity, accounting for changes in disease prevalence and demographics.RESULTS:We estimate that among adults, prevalence of hypertension will increase from 51.2% in 2020 to 61.0%

Risk Factors 81

Risk Factors Cardiovascular Disease Stroke Strokes 81

Journal of the American Heart Association

MARCH 18, 2024

Changes in BCAA homeostasis have emerged as pivotal contributors in the pathophysiology of several cardiometabolic diseases, including type 2 diabetes, obesity, hypertension, atherosclerotic cardiovascular disease, and heart failure.

Circulation 40

Circulation Obesity Heart Failure Cardiovascular Disease 40

Frontiers in Cardiovascular Medicine

JULY 22, 2024

years to monitor MACEs (cardiovascular death, cardiogenic shock, recurrent myocardial infarction, and heart failure).ResultsWe Hypertension (42.4%), smoking (34.3%), type 2 diabetes mellitus (31.2%), obesity (22.92%), and dyslipidemia (21.4%) were highly prevalent. Patients were followed up for 4.5

Myocardial Infarction 59

Myocardial Infarction Risk Factors Cardiogenic Shock STEMI 59

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionCardiomyopathy (CM) is a diverse pathology defined by both structural and functional changes in the heart. 24.2%, p < 0.001), diabetes mellitus (39.7% 37.6%, p < 0.001), obesity (9.2% Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. 16.4%, p < 0.001).

Heart Failure 40

Heart Failure Cardiomyopathy Inpatient Stroke 40

DAIC

SEPTEMBER 11, 2024

A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. Earlier projections had estimated that 3.3 million U.S. The study appears Sept. The study appears Sept.

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 52

ADN Center of Excellence

SEPTEMBER 2, 2024

AFib is associated with a fivefold increased risk of stroke, and it is also linked to heart failure, chronic fatigue, and other serious health issues. Factors such as aging populations, rising rates of obesity, hypertension, and other cardiovascular conditions contribute to this increase.

AFIB 59

AFIB Atrial Fibrillation Innovation Education 59

Stroke Journal

FEBRUARY 1, 2024

Regarding comorbidities, congestive heart failure (OR 1.73, p <0.01, CI 1.32 Regarding comorbidities, congestive heart failure (OR 1.73, p <0.01, CI 1.32 to 2.26) and liver disease (OR 2.20, p < 0.01, CI 1.27 to 2.26) and liver disease (OR 2.20, p < 0.01, CI 1.27

Inpatient 40

Inpatient Stroke Strokes Coronary Artery Disease 40

Wellnest

FEBRUARY 28, 2023

Insufficient or interrupted sleep can affect blood pressure and increase the risk of heart attacks, stroke, diabetes, and other cardiovascular diseases. High blood pressure and heart disease are related to insomnia. Sleep Issues Are Caused by Heart Failure Heart failure complications may impact your sleep.

Blood Pressure 52

Blood Pressure Heart Failure Heart Attack Heart attacks 52

DAIC

DECEMBER 19, 2023

The device is a patented 3-lead, 2-channel wireless continuous ECG wearable device that allows physicians the ability to address and assess sleep and heart health remotely. Undiagnosed and untreated sleep apnea increases the risk of costly health complications like heart disease, hypertension, diabetes, and depression.

Heart Failure 52

Heart Failure Heart Disease Innovation Quality of Life 52

Stroke Journal

FEBRUARY 1, 2024

Additionally, those with a history of kidney failure (2, 1.76 - 2.27), liver disease (1.32, 1.11 - 1.56), and heart failure (1.59, 1.35 - 1.86) had higher odds of experiencing MAVE.

Inpatient 40

Inpatient Hypertension Document Obesity 40

Stroke Journal

FEBRUARY 1, 2024

VRFs included hypertension, dyslipidemia, obesity, smoking, atrial fibrillation, coronary artery disease, heart failure, diabetes, and sleep apnea. Patients aged 18-55 with a diagnosis of IS were included and separated into two age groups: 18-35 and 36-55.

Risk Factors 40

Risk Factors Stroke Strokes Coronary Artery Disease 40

AMS Cardiology

AUGUST 15, 2023

It damages blood vessels, decreases oxygen to the heart and raises the risk of heart disease. Obesity and poor diet – Being overweight coupled with other risk factors can lead to heart problems. Heart issues can encompass a wide range of problems, from coronary artery disease to heart failure, arrhythmias and more.

Heart Disease 52

Heart Disease Blood Pressure Risk Factors Cholesterol 52

Cardiometabolic Health Congress

SEPTEMBER 13, 2024

ARIES-HM3 Subgroup Analysis: Nir Uriel, MD (USA) presented findings from a subgroup analysis of ARIES-HM3, showing that avoiding aspirin in newly implanted HeartMate 3 LVAD patients with atrial fibrillation, diabetes, and obesity significantly reduces non-surgical bleeding events at one year while maintaining safety.

Hypertension 59

Hypertension Cardiovascular Disease Bicuspid/Mitral Arrhythmia 59

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Patients readmitted within 30 days were more likely to be older (mean age = 61.92 years; p<0.001) and male (43.96% vs 41.74%; p=0.002) compared to those not requiring readmission. ConclusionThe annual rate of 90‐day readmission, but not 30‐day readmission, increased from 2016 to 2019.

Hemorrhage 40

Hemorrhage Coronary Artery Disease Obesity Heart Failure 40

DAIC

FEBRUARY 29, 2024

12:15 p.m.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

They also had a higher prevalence of diabetes (32.43% and 32.82% vs 28.42%), dyslipidemia (44.57% and 44.81% vs 41.41%), obesity (13.19% and 13.64% vs 12.03%), prior TIA/ischemic stroke (6.46% and 6.52&

Hemorrhage 40

Hemorrhage Risk Factors Coronary Artery Disease Obesity 40

DAIC

DECEMBER 8, 2023

If untreated, AFib can lead to or exacerbate heart failure, and it significantly increases a person’s risk of stroke. Catheter ablation was given the highest Class 1 treatment recommendation for appropriately selected patients, including those with heart failure with reduced ejection fraction.

Atrial Fibrillation 52

Atrial Fibrillation AFIB Stroke Strokes 52

CardiacWire

AUGUST 2, 2024

Lilly’s blockbuster GLP-1 tirzepatide appears poised to become the next major HFpEF drug, after topline results from the SUMMIT trial showed that it significantly improved both outcomes and symptoms among patients with heart failure with preserved ejection fraction and obesity. vs. +15 KCCQ-CSS points).

Outcomes 59

Outcomes Preserved Ejection Fraction Heart Failure Obesity 59

DAIC

JUNE 26, 2024

Getty Images milla1cf Wed, 06/26/2024 - 18:59 June 26, 2024 — Semaglutide , a medication initially developed for type 2 diabetes and obesity, significantly improves symptoms in men and women with a common type of heart failure that has had few therapeutic options. The study analyzed the effects of semaglutide 2.4

Preserved Ejection Fraction 105

Preserved Ejection Fraction Obesity BMI Heart Failure 105

DAIC

JUNE 18, 2024

A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 trillion by 2050, according to two American Heart Association ( AHA ) presidential advisories published June 4 in the AHA journal Circulation.

Heart Disease 105

Heart Disease Blood Pressure Stroke Strokes 105

Physiologically Speaking

DECEMBER 15, 2023

Blood glucose control Resistance exercise training can reduce fasting glucose by 2–5 mg/dL in adults with prediabetes and type 2 diabetes but doesn’t seem to reduce blood glucose in healthy adults (not surprising). a higher metabolism). Of course, these benefits can also extend to individuals with a BMI in the normal range.

Physiology 52

Physiology Exercise Blood Pressure Risk Factors 52